S100 (A1B and BB), creatine phosphokinase and lactic dehydrogenase serum levels in Greek stroke patients. Relation to clinical outcome. A preliminary report

Mouzak, AM; Agathos, P; Kontopadelis, E; Alevra, A; Kouvardas, S; Vogiatzakis, E; Vourdeli-Giannakoura, E

dc.contributor.author	Mouzak, AM	en
dc.contributor.author	Agathos, P	en
dc.contributor.author	Kontopadelis, E	en
dc.contributor.author	Alevra, A	en
dc.contributor.author	Kouvardas, S	en
dc.contributor.author	Vogiatzakis, E	en
dc.contributor.author	Vourdeli-Giannakoura, E	en
dc.date.accessioned	2014-03-01T11:45:55Z
dc.date.available	2014-03-01T11:45:55Z
dc.date.issued	2005	en
dc.identifier.issn	1351-5101	en
dc.identifier.uri	https://dspace.lib.ntua.gr/xmlui/handle/123456789/37710
dc.subject.classification	Clinical Neurology	en
dc.subject.classification	Neurosciences	en
dc.title	S100 (A1B and BB), creatine phosphokinase and lactic dehydrogenase serum levels in Greek stroke patients. Relation to clinical outcome. A preliminary report	en
heal.type	other	en
heal.language	English	en
heal.publicationDate	2005	en
heal.publisher	WILEY-BLACKWELL PUBLISHING, INC	en
heal.journalName	EUROPEAN JOURNAL OF NEUROLOGY	en
dc.identifier.isi	ISI:000202992200532	en
dc.identifier.volume	12	en
dc.identifier.spage	174	en
dc.identifier.epage	175	en